Draft guidance | Spectra Optia for automatic red blood cell exchange in people with sickle cell disease | Guidance

This page provides links to the consultation documents for the NICE evaluation of Spectra Optia Apheresis System for automated red blood cell exchange in patients with sickle cell disease

Consultation on these documents will open on 19 October 2015 at 9.00am and close on 16 November 2015 at 9.00am. NICE would like to receive comments on these documents from anyone who has an interest in the technology, or the area of treatment in general.

Comments should be made via the website or e-mail to MT271SpectraOptia@nice.org.uk

Further information about the NICE Medical Technologies Evaluation programme.

Final scope ^{PDF 185 KB} 19 October 2015
Overview of assessment report ^{PDF 573 KB} 19 October 2015
Correspondence with EAC ^{PDF 340 KB} 19 October 2015
Assessment report ^{PDF 1.93 MB} 19 October 2015
Overview of assessment report ^{PDF 573 KB} 19 October 2015
Supporting documentation Additional information from EAC ^{PDF 282 KB} 19 October 2015
Consultation document ^{MSWord 78 KB} 19 October 2015
Submission of evidence by sponsor ^{PDF 2.23 MB} 05 November 2015
Supporting documentation ^{PDF 292 KB} 02 March 2016

This page was last updated: 19 October 2015